The results of Deutsche Bank and AstraZeneca's phase 2 test, along with disappointing progress in their lung cancer treatment, caused European markets to plummet. Wall Street broke records at the opening of the session, while Facebook made headlines for a strong Q2 and investors took advantage of rising inflation rates.